PROGNOSTIC FACTORS IN RESECTED HEPATOCELLULAR CARCINOMAS AND THERAPEUTIC VALUE OF TRANSCATHETER ARTERIAL EMBOLIZATION FOR RECURRENCES

Citation
H. Kimura et al., PROGNOSTIC FACTORS IN RESECTED HEPATOCELLULAR CARCINOMAS AND THERAPEUTIC VALUE OF TRANSCATHETER ARTERIAL EMBOLIZATION FOR RECURRENCES, International surgery, 83(2), 1998, pp. 146-149
Citations number
12
Categorie Soggetti
Surgery
Journal title
ISSN journal
00208868
Volume
83
Issue
2
Year of publication
1998
Pages
146 - 149
Database
ISI
SICI code
0020-8868(1998)83:2<146:PFIRHC>2.0.ZU;2-7
Abstract
The authors summarize the results of patients who had hepatectomy for hepatocellular carcinoma (HCC) over a 16-year period. Survival rates f or 52 patients with HCC classified according to the Liver Cancer Study Group of Japan were calculated according to various clinicopathologic al variables. A univariable analysis revealed that alpha-fetoprotein g reater than or equal to 2000 ng/ml, portal involvement, tumor size gre ater than or equal to 3.1 cm, and noncurative resection were associate d with unfavorable outcomes, while neither the number of tumors nor un derlying cirrhosis was associated with such outcomes. Furthermore, som e of the patients with recurrence survived long after transcatheter ar terial embolization (TAE) for recurrent tumors. Early detection as wel l as TAE for recurrent HCCs is necessary to improve long-term survival .